Welcome to our dedicated page for SOMNIGROUP INTERNATIONAL SEC filings (Ticker: SGI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Somnigroup International Inc. filings document regulatory disclosures for a NYSE-listed bedding company with common stock trading under SGI. Form 8-K reports cover operating and financial results, financial guidance, quarterly cash dividends, Regulation FD investor presentations, and other material-event disclosures tied to its omnichannel bedding platform.
Proxy materials describe board and shareholder voting matters, executive compensation, equity awards and governance practices. Company disclosures also identify business segments such as Mattress Firm, Tempur Sealy North America and Tempur Sealy International, along with capital-structure information for its common stock.
NEU RICHARD W reported acquisition or exercise transactions in this Form 4 filing.
Somnigroup International Inc. director Richard W. Neu reported an award of 2,657 restricted stock units tied to the company’s common stock. Each unit represents the right to receive one share of common stock, and the units vest in full on the first anniversary of the grant date. Following this equity award, Neu directly holds 173,812 shares of Somnigroup common stock.
Madden Meredith Siegfried reported acquisition or exercise transactions in this Form 4 filing.
SomniGroup International Inc. director Meredith Siegfried Madden received a grant of 2,657 restricted stock units on May 13, 2026, at no cash cost. Each unit represents one share of common stock and vests in full on the first anniversary of the grant date, bringing her direct holdings to 17,780 shares.
Gates Cathy R. reported acquisition or exercise transactions in this Form 4 filing.
Somnigroup International Inc. director Cathy R. Gates received an equity award of 2,657 restricted stock units, each representing one share of common stock. The grant was made at no cash cost to her. These restricted stock units vest in full on the first anniversary of the grant date.
Following this award, Gates directly holds 41,232 shares of Somnigroup common stock. This filing reflects routine stock-based compensation rather than an open-market purchase or sale.
Dilsaver Evelyn S reported acquisition or exercise transactions in this Form 4 filing.
SOMNIGROUP INTERNATIONAL INC. director Evelyn S. Dilsaver received a grant of 2,657 restricted stock units, representing the right to receive an equal number of common shares. The award was recorded at a price of $0.00 per share as a compensation grant, not an open-market purchase.
The restricted stock units vest in full on the first anniversary of the grant date. After this award, Dilsaver’s direct ownership increased to 156,574 shares of common stock, showing this as a relatively small, routine addition to her existing stake.
SOMNIGROUP INTERNATIONAL INC. director Christopher Thomas Cook received a grant of 2,657 shares of common stock in the form of restricted stock units. These units vest in full on the first anniversary of the grant date and will then convert into shares. Following this equity award, Cook holds 124,110 shares directly.
Somnigroup International Inc. director Peter R. Sachse reported an acquisition of 2,657 shares of common stock through a grant of restricted stock units. Each restricted stock unit represents the right to receive one share of common stock and vests in full on the first anniversary of the grant date. Following this grant, Sachse directly holds 65,947 shares of Somnigroup common stock.
SOMNIGROUP INTERNATIONAL INC. director Simon Dyer reported several equity compensation transactions in company stock. On May 14, 2026, he exercised 2,337 restricted stock units, converting them into the same number of common shares on a one-for-one basis, and a portion of the resulting shares was used to satisfy tax obligations.
Specifically, 702 common shares were disposed of at $64.49 per share in a tax-withholding disposition, while his direct common stock holdings increased, with 11,582 shares shown as held directly after the exercise. On May 13, 2026, he also received a grant of 2,657 restricted stock units, each representing the right to receive one common share that vests in full on the first anniversary of the grant date.
The filing further shows 36,800 common shares held indirectly through Madad Investments Pty Ltd, an entity for which Dyer, as a shareholder, has sole control over investment and voting decisions.
Somnigroup International Inc. reported that stockholders approved an amendment to its Amended and Restated Certificate of Incorporation to increase authorized common stock from 500,000,000 to 1,000,000,000 shares, keeping authorized preferred stock at 10,000,000 shares for a total of 1,010,000,000 authorized shares.
At the 2026 Annual Meeting, held on May 13, 2026, stockholders elected all director nominees, ratified Ernst & Young LLP as independent auditor for the year ending December 31, 2026, and approved on an advisory basis the compensation of named executive officers.
Somnigroup International Inc. reported strong first-quarter 2026 results, with net sales of $1,801.5 million, up 12.3% from $1,604.7 million a year earlier, helped by a full-quarter contribution from the Mattress Firm segment. Gross margin expanded to 43.1% from 36.2%, and operating income jumped to $187.1 million from $13.2 million, reflecting synergies and lower one-time acquisition charges.
Net income attributable to Somnigroup was $104.2 million, versus a loss of $(33.1) million in the prior-year quarter, with diluted EPS of $0.49. Adjusted net income was $124.5 million and adjusted EBITDA $296.8 million. Somnigroup also signed a definitive all-stock agreement to acquire Leggett & Platt in a transaction valued at approximately $2.5 billion, and ended the quarter with $873.5 million of liquidity and a leverage ratio of 3.07x under its credit agreement.
Somnigroup International released an investor presentation outlining strong recent results and an aggressive growth plan. For the quarter ended March 31, 2026, net sales were $1.802 billion, up 12.3%, with net income of $104.2 million versus a prior-year loss and adjusted EPS of $0.59.
Trailing-twelve-month net income reached $521.4 million and adjusted EBITDA $1.355 billion, while leverage was about 3.1x. For 2026, Somnigroup targets roughly $7.8 billion in sales, adjusted EBITDA of $1.45 billion, and adjusted EPS between $3.00 and $3.40, supported by about $700 million of advertising and $225 million of capital spending.
The presentation highlights integration of Mattress Firm, with expected net EBITDA synergies of $235 million by 2027, and a planned all‑stock acquisition of Leggett & Platt valued around $2.5 billion, expected to be immediately accretive to adjusted EPS, reduce net leverage, and add about $50 million of annual EBITDA synergies at full run rate.